99% Savings - Buy Just @1 Rs X
Gemi, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Bronchitis. Other than this, Gemi has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Gemi. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Gemi are Nausea or vomiting, Diarrhoea, Dizziness. Apart from the aforementioned side effects, Gemi can also lead to other problems, which have been listed below. Usually, these side effects of Gemi go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Gemi's effect is Moderate during pregnancy and Severe for lactating mothers. Further, the section on Gemi related warnings talks about Gemi's effects on the liver, heart and kidney.
Gemi is not recommended if you suffer from certain medical conditions as it can have adverse effects. Myasthenia Gravis (MG), Heart Disease, Tendon Injury (Tendinopathy) are examples of such conditions. Some other conditions that can be affected by Gemi are listed in the contraindications section below.
Besides this, Gemi may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Gemi is not safe while driving, and is not addiction.
Gemi is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gemi safe for pregnant women?
Gemi can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Gemi right away. Take your doctor's advice before taking it again.
Is the use of Gemi safe during breastfeeding?
Gemi should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Gemi on the Kidneys?
Gemi may have mild side effects on the kidneys.
What is the effect of Gemi on the Liver?
There are no any side effects of Gemi on the liver.
What is the effect of Gemi on the Heart?
Gemi may have mild side effects on the heart. Most people will never see any effect on the heart.
Gemi should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gemi unless your doctor advises you to do so -
Is this Gemi habit forming or addictive?
Gemi does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Gemi can make you feel drowsy.
Is it safe?
Gemi is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Gemi is unable to treat or cure mental disorders.
Interaction between Food and Gemi
Gemi may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Gemi
No research has been done on this till date. Therefore, it is not known what the effect of taking Gemi with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Factive® (gemifloxacin mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584